Composition for treatment of undifferentiated-type of gastric cancer

Details for Australian Patent Application No. 2008211952 (hide)

Owner Eisai R & D Management Co., Ltd.

Inventors Yamamoto, Yuji

Agent FB Rice

Pub. Number AU-B-2008211952

PCT Pub. Number WO2008/093855

Priority 60/887,006 29.01.07 US

Filing date 28 January 2008

Wipo publication date 7 August 2008

Acceptance publication date 19 July 2012

International Classifications

C07D 215/22 Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

A61K 31/337 - having four-membered rings, e.g. taxol

A61K 31/403 - condensed with carbocyclic rings, e.g. carbazole

A61K 31/4439

A61K 31/4545

A61K 31/47 - Quinolines

A61K 31/4709 - Non-condensed quinolines containing further heterocyclic rings

A61K 31/513 - having oxo groups directly attached to the heterocyclic ring, e.g. cytosine

A61P 35/00 Antineoplastic agents

A61P 43/00 Drugs for specific purposes, not provided for in groups

Event Publications

20 August 2009 PCT application entered the National Phase

  PCT publication WO2008/093855 Priority application(s): WO2008/093855

19 July 2012 Application Accepted

  Published as AU-B-2008211952

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008211977-Powdery soybean mixture

2008211950-Solid of macrolide compound, method for production thereof, and pharmaceutical composition comprising the same